JPND: Personalized Medicine for Neurodegenerative Diseases

The EU Joint Program - Neurodegenerative Disease Research (JPND) will & nbsp; shortly launch a new cohesive action with the European Commission - a call for " Multinational research projects on Personalized Medicine for Neurodegenerative Diseases ". More than € 30 million have already been earmarked by JPND member countries and the European Commission for this action.

Neurodegenerative diseases are debilitating and still largely untreatable conditions. They are characterized by a large variability in their origins, mechanisms and clinical expression. When searching for a medical solution, eg a treatment or an optimized approach for care, this large variability constitutes a major hurdle if not controlled. Indeed a treatment addressing one disease pathway may not be useful for all patients experiencing the relevant symptoms. Thus, one of the greatest challenges for treating neurodegenerative diseases is the deciphering of this variability.

JPND has chosen to focus in the area of Precision Medicine, which relates to the targeting of specific elements responsible for pathology in a given individual at a particular point in time. It is an emerging approach for disease prevention, diagnosis and treatment that takes into account individual variability in genes, biological / molecular characteristics together with environmental and lifestyle factors.

Read more about the call and how to apply here